{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T21:03:28Z","timestamp":1785791008125,"version":"3.56.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Nos. 81502992, 81302826, 81473280"],"award-info":[{"award-number":["Nos. 81502992, 81302826, 81473280"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.phymed.2018.09.006","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T09:23:16Z","timestamp":1536139396000},"page":"134-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor"],"prefix":"10.1016","volume":"53","author":[{"given":"Renchao","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0699-8452","authenticated-orcid":false,"given":"Kexin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokui","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5741-0719","authenticated-orcid":false,"given":"Qiang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2018.09.006_bib0001","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.bbagrm.2016.03.002","article-title":"Nuclear receptors and nonalcoholic fatty liver disease","volume":"1859","author":"Cave","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phymed.2018.09.006_bib0002","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease","volume":"152","author":"Chavez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phymed.2018.09.006_bib0003","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.4254\/wjh.v7.i9.1251","article-title":"Valproic acid and nonalcoholic fatty liver disease: a possible association?","volume":"7","author":"Farinelli","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.phymed.2018.09.006_bib0004","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bcp.2017.04.014","article-title":"Apigenin, a modulator of PPARgamma, attenuates HFD-induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation","volume":"136","author":"Feng","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phymed.2018.09.006_bib0005","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0092-8674(95)90530-8","article-title":"Identification of a nuclear receptor that is activated by farnesol metabolites","volume":"81","author":"Forman","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2018.09.006_bib0006","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bcp.2015.12.020","article-title":"Coral calcium hydride prevents hepatic steatosis in high fat diet-induced obese rats: a potent mitochondrial nutrient and phase II enzyme inducer","volume":"103","author":"Hou","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phymed.2018.09.006_bib0007","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/hep.29199","article-title":"Hepatic FXR\/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice","volume":"66","author":"Kim","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2018.09.006_bib0008","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/BF02618288","article-title":"Mouse liver cell culture. I. Hepatocyte isolation","volume":"17","author":"Klaunig","year":"1981","journal-title":"In Vitro"},{"key":"10.1016\/j.phymed.2018.09.006_bib0009","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2018.02.002","article-title":"Protective effects of yangonin from an edible botanical Kava against lithocholic acid-induced cholestasis and hepatotoxicity","volume":"824","author":"Kong","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phymed.2018.09.006_bib0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.phrs.2012.04.003","article-title":"Kavalactones and the endocannabinoid system: the plant-derived yangonin is a novel CB(1) receptor ligand","volume":"66","author":"Ligresti","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2018.09.006_bib0011","doi-asserted-by":"crossref","first-page":"7973","DOI":"10.1038\/srep07973","article-title":"Potent effects of dioscin against obesity in mice","volume":"5","author":"Liu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2018.09.006_bib0012","doi-asserted-by":"crossref","first-page":"408","DOI":"10.7555\/JBR.31.20160160","article-title":"Kavalactone yangonin induces autophagy and sensitizes bladder cancer cells to flavokawain A and docetaxel via inhibition of the mTOR pathway","volume":"31","author":"Liu","year":"2017","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.phymed.2018.09.006_bib0013","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s11095-013-0986-7","article-title":"Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance","volume":"30","author":"Ma","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phymed.2018.09.006_bib0014","doi-asserted-by":"crossref","first-page":"44819","DOI":"10.1038\/srep44819","article-title":"Beneficial effects of paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats","volume":"7","author":"Ma","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2018.09.006_bib0015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1210\/me.2002-0120","article-title":"Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor","volume":"17","author":"Pineda Torra","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.phymed.2018.09.006_bib0016","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","article-title":"Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases","volume":"27","author":"Samuel","year":"2018","journal-title":"Cell Metabol."},{"key":"10.1016\/j.phymed.2018.09.006_bib0017","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jhep.2015.07.036","article-title":"Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial","volume":"63","author":"Scorletti","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2018.09.006_bib0018","doi-asserted-by":"crossref","first-page":"11077","DOI":"10.3748\/wjg.v21.i39.11077","article-title":"Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance","volume":"21","author":"Stal","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phymed.2018.09.006_bib0019","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1007\/s13197-013-1047-2","article-title":"Kavalactone content and chemotype of kava beverages prepared from roots and rhizomes of Isa and Mahakea varieties and extraction efficiency of kavalactones using different solvents","volume":"52","author":"Wang","year":"2015","journal-title":"J. Food Sci. Technol."},{"key":"10.1016\/j.phymed.2018.09.006_bib0020","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phymed.2018.09.006_bib0021","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1124\/mol.107.042499","article-title":"Kavalactones protect neural cells against amyloid beta peptide-induced neurotoxicity via extracellular signal-regulated kinase 1\/2-dependent nuclear factor erythroid 2-related factor 2 activation","volume":"73","author":"Wruck","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phymed.2018.09.006_bib0022","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12072-010-9202-6","article-title":"Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease","volume":"4","author":"Yang","year":"2010","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.phymed.2018.09.006_bib0023","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.4254\/wjh.v7.i28.2811","article-title":"Bile acid receptors and nonalcoholic fatty liver disease","volume":"7","author":"Yuan","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.phymed.2018.09.006_bib0024","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1073\/pnas.0506982103","article-title":"Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phymed.2018.09.006_bib0025","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1007\/s10620-015-3728-3","article-title":"Prevalence of nonalcoholic fatty liver disease and economy","volume":"60","author":"Zhu","year":"2015","journal-title":"Digestive Dis. Sci."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711318302873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711318302873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T18:16:48Z","timestamp":1661969808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711318302873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":25,"alternative-id":["S0944711318302873"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2018.09.006","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2018.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}